Gelesis Holdings, Inc. (GLSH)
OTOTC · Common · CUSIP 14070Y101
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for GLSH and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
14070Y101
Market Cap
Micro Cap · $27 Million
IPO
7/2/2020
Previous Symbol
GLS (changed 4/11/2023)
Previous Name
Capstar Special Purpose Acquisition Corp
Business: Gelesis Holdings, Inc. is a consumer-centered biotherapeutics company and the maker of Plenity®, which is inspired by nature and FDA cleared to aid in weight management. The Company's first-of-their-kind non-systemic superabsorbent hydrogels are made entirely from naturally derived building blocks.

Company Contact

CEO
Yishai Zohar
CFO
Elliot Maltz
Headquarters
501 Boylston Street, Suite 6102, Boston, MA 02116
Phone
617-456-4718
Investor Relations
Katie Sullivan · 617-456-4718 · ksullivan@gelesis.com
SEC EDGAR Filings
View filings »
Find all related securities for GLSH »